Published Articles
PSP Faculty Research Interests:
Dr. Khalid M. Kamal, MPharm, PhD:
Dr. Khalid Kamal's primary research and teaching interests have been pharmacoeconomics, patient-reported outcomes research, and improving quality of care using real-world data sources such as electronic medical records and specialty pharmacy data. Over the years, his research has focused on issues such as cost-effectiveness of treatments, quality of life, productivity costs, economic burden of diseases, and issues related to quality of care in chronic and rare conditions.
As a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) since 2000, Dr. Kamal has held several leadership positions and volunteer roles and actively contributed to ISPOR’s mission and activities. Dr. Kamal currently serves as the Associate Editor of Value in Health, the flagship journal of ISPOR. In the past, he has served as the Chair of the Faculty Advisory Council (2019-2023); as a member of the Health Science Policy Council and Education Council; Co-Chair of the Oncology Special Interest Group (2016-2019); Faculty Advisor of Duquesne University ISPOR Student Chapter (2006-2020) and as a co-Guest Editor on a Themed Issue on Prescription Drug Pricing published in Value in Health in March 2023. Outside of ISPOR, Dr. Kamal currently serves on the Editorial Advisory Board of the Journal of Managed Care and Specialty Pharmacy (2023-2026), the flagship journal of the Academy of Managed Care Pharmacy.
Dr. Virginia G. Scott, RPh, MS, PhD:
Dr. Scott is a Professor in the Department of Pharmaceutical Systems and Policy and Director of Continuing Education at the West Virginia University School of Pharmacy. She joined the faculty of WVU in 1994 where she teaches courses in Outcomes and Quality Improvement, Patient Health Education, and Pharmacoeconomics. Dr. Scott's focus has been to educate and train students and pharmacists to provide services which will enhance the patient's quality of life. She is a frequent lecturer on medication error reduction, quality improvement, and methods to redesign pharmacies to provide optimal care. She has also worked extensively with the West Virginia Medicaid Program to improve the quality of pharmacy services to the citizens of West Virginia. She has published in peer review journals and given presentations on the local, state, and national levels. Dr. Scott has been and continues to be active in professional pharmacy organizations on the local, state, and national levels.
Dr. Abdullah Al-Mamun, PhD:
Dr. Al-Mamun's research provides cutting-edge methods and tools to interpret and address the research questions related to health outcomes, big data, and epidemiological surveillance systems. His current research is expanded three themes: (1) understanding acute, and chronic kidney diseases, and their relationship with type-2 diabetes using heterogeneous data such as electronic health record data, national survey data, microscopic image data, and state-level surveillance data, (2) understanding polysubstance use among the people who use opioids using sate- and national-level surveillance datasets, (3) understanding medication regimen complexity among critically ill patients and (3) understanding spatiotemporal dynamics of different infectious diseases (e.g., vector-borne diseases, Covid-19) in the USA using national-level surveillance datasets.
Dr. Sabina Nduaguba, PhD:
Dr. Sabina Nduaguba is an Assistant Professor in Department of Pharmaceutical Systems and Policy at West Virginia University School of Pharmacy. She obtained her master’s and doctoral degrees in Pharmaceutical Sciences (Health Outcomes) at the University of Texas at Austin. Prior to joining the Department, Dr Nduaguba completed a postdoctoral fellowship at University of Florida on the application of advanced epidemiologic methods in research design and real-world evidence generation. Dr Nduaguba’s research focuses on 1) cancer prevention and control through smoking cessation; 2) health disparities among people with cancer related to healthcare access along the cancer care continuum; and 3) the application of genetically-informed pharmacological treatment to improve health outcomes. Dr. Nduaguba holds a joint faculty position with the Cancer Institute.